azelastine has been researched along with Cough in 8 studies
azelastine: azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia
azelastine : A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.
Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effects of azelastine in patients with cough-variant asthma, we measured the cough threshold for capsaicin (the concentration required to elicit more than five coughs) in 16 patients with cough-variant asthma before and after 4 weeks of treatment with azelastine (2 mg; b." | 9.08 | Cough threshold for capsaicin increases by azelastine in patients with cough-variant asthma. ( Ito, N; Kagaya, M; Kashima, M; Miura, M; Sano, M; Sasaki, M; Shindo, T; Shioya, T, 1996) |
| "To investigate the efficacy of azelastine hydrochloride (azelastine, CAS 79307-93-0, Azeptin) in suppressing cough, 22 bronchial asthma patients complaining mainly of cough were given the drug for four weeks." | 9.08 | Antitussive effect of azelastine hydrochloride in patients with bronchial asthma. ( Ito, N; Kagaya, M; Kimura, K; Miura, M; Miura, S; Sano, M; Shindo, T; Shioya, T; Watanabe, A, 1998) |
| "To assess the effects of azelastine in patients with cough-variant asthma, we measured the cough threshold for capsaicin (the concentration required to elicit more than five coughs) in 16 patients with cough-variant asthma before and after 4 weeks of treatment with azelastine (2 mg; b." | 5.08 | Cough threshold for capsaicin increases by azelastine in patients with cough-variant asthma. ( Ito, N; Kagaya, M; Kashima, M; Miura, M; Sano, M; Sasaki, M; Shindo, T; Shioya, T, 1996) |
| "To investigate the efficacy of azelastine hydrochloride (azelastine, CAS 79307-93-0, Azeptin) in suppressing cough, 22 bronchial asthma patients complaining mainly of cough were given the drug for four weeks." | 5.08 | Antitussive effect of azelastine hydrochloride in patients with bronchial asthma. ( Ito, N; Kagaya, M; Kimura, K; Miura, M; Miura, S; Sano, M; Shindo, T; Shioya, T; Watanabe, A, 1998) |
| "In order to clarify the mechanism of the antitussive effects of azelastine hydrochloride (azelastine, CAS 790307-93-0), the cough responses to inhaled capsaicin and substance P (SP) were evaluated before and after the administration of azelastine in conscious guinea pigs." | 3.71 | Mechanism of the antitussive effect of azelastine in guinea pigs. ( Ito, N; Miura, M; Sano, M; Sasaki, M; Shioya, T; Watanabe, A, 2002) |
| "Rhinosinusitis was assessed by questionnaires, direct examination of the nose and by high-resolution computed tomography." | 1.35 | Postnasal drip and chronic cough: An open interventional study. ( Arbery, J; Chung, KF; Durham, SR; Macedo, P; MacKay, I; Saleh, H; Torrego, A, 2009) |
| "The cough was relieved by inhaled procaterol in 10 patients (Group 2) but not in the other 10 patients (Group 1)." | 1.28 | Bronchodilator-resistive cough in atopic patients: bronchial reversibility and hyperresponsiveness. ( Fujimura, M; Matsuda, T; Sakamoto, S, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, U | 1 |
| Bernstein, JA | 1 |
| Lorentz, H | 1 |
| Sadoway, T | 1 |
| Nelson, V | 1 |
| Patel, P | 1 |
| Salapatek, AM | 1 |
| Fujimura, M | 2 |
| Macedo, P | 1 |
| Saleh, H | 1 |
| Torrego, A | 1 |
| Arbery, J | 1 |
| MacKay, I | 1 |
| Durham, SR | 1 |
| Chung, KF | 1 |
| Ito, N | 3 |
| Shioya, T | 3 |
| Watanabe, A | 2 |
| Sano, M | 3 |
| Sasaki, M | 2 |
| Miura, M | 3 |
| Kagaya, M | 2 |
| Shindo, T | 2 |
| Kashima, M | 1 |
| Miura, S | 1 |
| Kimura, K | 1 |
| Sakamoto, S | 1 |
| Matsuda, T | 1 |
| Ohya, Y | 1 |
| Kumamoto, K | 1 |
| Fujishima, M | 1 |
1 review available for azelastine and Cough
| Article | Year |
|---|---|
[Causes of prolonged and chronic cough].
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Chronic Disease; Clenbuterol; Cough; Dr | 2008 |
4 trials available for azelastine and Cough
| Article | Year |
|---|---|
A Pilot Study Investigating Clinical Responses and Biological Pathways of Azelastine/Fluticasone in Nonallergic Vasomotor Rhinitis before and after Cold Dry Air Provocation.
Topics: Adult; Air; Anti-Inflammatory Agents; Bronchial Provocation Tests; Cold Temperature; Cough; Female; | 2017 |
Cough threshold for capsaicin increases by azelastine in patients with cough-variant asthma.
Topics: Adult; Aged; Asthma; Bronchodilator Agents; Capsaicin; Cough; Dose-Response Relationship, Drug; Fema | 1996 |
Antitussive effect of azelastine hydrochloride in patients with bronchial asthma.
Topics: Adolescent; Adult; Aged; Anti-Asthmatic Agents; Antitussive Agents; Asthma; Bronchial Hyperreactivit | 1998 |
Effects of crossover application of sulindac and azelastine on enalapril-induced cough.
Topics: Adult; Aged; Bronchodilator Agents; Cough; Enalapril; Female; Humans; Male; Middle Aged; Phthalazine | 1992 |
3 other studies available for azelastine and Cough
| Article | Year |
|---|---|
Postnasal drip and chronic cough: An open interventional study.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Androstadienes; Anti-Inflammatory Agents, Non-S | 2009 |
Mechanism of the antitussive effect of azelastine in guinea pigs.
Topics: Animals; Antitussive Agents; Bronchoalveolar Lavage Fluid; Capsaicin; Cough; Female; Guinea Pigs; Ph | 2002 |
Bronchodilator-resistive cough in atopic patients: bronchial reversibility and hyperresponsiveness.
Topics: Adrenergic beta-Agonists; Adult; Aged; Bronchi; Bronchodilator Agents; Cough; Drug Resistance; Ethan | 1992 |